A Phase II trial directly comparing the tablet and vaginal gel formulations of the antiretroviral drug tenofovir, looking at women’s adherence to and acceptance of three daily regimens – tenofovir gel, tenofovir tablet and the two together – and how the drug is absorbed by and distributed in the body.
See
Tenofovir Gel Wins Out in Drug Absorption Study, but HIV Prevention Trials Tell a Different Story
Jan 30, 2013
HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
Jul 9, 2008
See Also
